The report “Porcine Vaccines Market, By Type, By Disease Indication, and By Region - Trends, Analysis and Forecast till 2030”

COVINA, CALIFORNIA , UNITED STATE, April 6, 2023/EINPresswire.com/ -- The Porcine Vaccine Market accounted for US$ 2.23 billion in 2020 and is estimated to be US$ 4.41 billion by 2030 and is anticipated to register a CAGR of 7.50%. The growth of huge, intensive pig operations has made effective vaccination imperative within the swine industry. This growth in size has been amid outbreaks of disease like porcine respiratory and reproductive syndrome (PRRS) and porcine epidemic diarrhea. These have caused massive losses, and effective vaccines aren't yet available. Older diseases like pleuropneumonia, erysipelas, enzootic pneumonia, proliferative enteritis, pseudorabies, and colibacillosis still persist, and classical swine fever and influenza remain as ongoing threats. The massive size of the many operations has required the introduction of mass vaccination procedures like vaccination through beverage. The present African swine fever pandemic makes the event of an efficient vaccine against this virus, a matter of urgent necessity.

The report “Porcine Vaccines Market, By Type (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and DNA Vaccines), By Disease Indication (PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine Influenza, Aujeszky’s Disease (AD), Porcine Circovirus Associated Disease (PCVAD), By End-User (Veterinary Hospitals & Hog Production Farm and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

Key Highlights:
• In May 2019, Hipra launched two new swine vaccines within the South Korean marketplace for regional expansion.
• In 2021, Zoetis announced the launch of CircoMax Myco, in the European Union. It is the first, and only, vaccine that includes two porcine circovirus type 2 (PCV2) genotypes (a & b), providing broader coverage against PCV2 and longest-lasting combined protection against two of the main pathogens in the global pig industry, PCV2 and Mycoplasma hyopneumoniae.

Analyst View:
The porcine vaccine market is especially driven by the demand for gelatin and pork meat, and an increase within the prevalence of swine diseases. The govt of the many countries take initiatives to determine large animal farms to supply fresh meat and poultry products to spice up the economy further contribute the expansion of the porcine vaccines market across the world. Increasing R&D investments by vaccine manufacturing companies, government initiatives, and demand for porcine meat are a number of the main factors propelling market growth. Moreover, the rising demand for meat, milk and animal proteins and growing concern over the prevalence of zoonotic diseases are factors driving the market. Vietnam is that the third largest pig meat eating country within the world, where a mean of 29.14 kg of pig meat was consumed in 2015

Request Free Sample:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2161

Scope of the Report:
1. Market Preview
>Executive Summary
>Key Findings—Global Outlook for Oncology Drug Strategies
• Key Questions this Study will Answer
• Market Snippet, By Type
• Market Snippet, By Disease Indication
• Market Snippet, By End-User
>Opportunity Map Analysis
>Executive Summary—3 Big Predictions
2. Market Dynamics, Regulations, and Trends Analysis
>Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Market Trends
>DR Impact Analysis
>PEST Analysis
>Porter’s Five Forces Analysis
>Opportunity Orbit
>Market Investment Feasibility Index
>Macroeconomic Factor Analysis
3. Global Porcine Vaccine Market, By Type, 2020 – 2030, (US$ Mn)
>Overview
• Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
• Y-o-Y Growth Analysis (%), 2020 – 2030
• Segment Trends
>Inactivated Vaccines
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Live Attenuated Vaccines
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Toxoid Vaccines
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Recombinant Vaccines
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Conjugate Vaccines
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>DNA Vaccines
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
4. Global Porcine Vaccine Market, By Disease Indication, 2020 – 2030, (US$ Mn)
>Overview
• Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
• Y-o-Y Growth Analysis (%), 2020 – 2030
• Segment Trends
>PED (Porcine Epidemic Diarrhea)
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>PRRS (Porcine Reproductive & Respiratory Syndrome)
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Swine Influenza
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Aujeszky’s Disease (AD)
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
>Porcine Circovirus Associated Disease (PCVAD)
• Overview
• Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

Key Market Insights from the report:
The Global Porcine Vaccine Market accounted for US$ 2.23 billion in 2020 and is estimated to be US$ 4.41 billion by 2030 and is anticipated to register a CAGR of 7.50%. The global porcine vaccines market report segments the market on the basis of type, disease indication, end-user, and region.
By Type, the Global Regenerative Medicine Market is segmented into Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and DNA Vaccines.
By Disease Indication, the Global Regenerative Medicine Market is segmented into PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), Swine Influenza, Aujeszky’s Disease (AD), Porcine Circovirus Associated Disease (PCVAD).
By End-User, the Global Regenerative Medicine Market is segmented into Veterinary Hospitals & Hog Production Farm and Others.
By region, the Global Regenerative Medicine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global porcine vaccine market in terms of revenue contribution as related to that of markets in other regions. This is attributed to the increasing government funds for the development of vaccines and the presence of dominant players in the market in this region.

Competitive Landscape:
• Bayer AG
• Bimeda
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale SA
• Eli Lilly and Company
• Merck & Co.
• Sanofi S.A.
• Vetoquinol S.A.
• Zoetis, Inc.
• Vitus Animal Health
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Questions answered by Porcine Vaccine Market:
1. What are some of the key drivers of growth in the porcine vaccine market?
The key drivers of growth in the porcine vaccine market include the increasing demand for pork products worldwide, the rising incidence of infectious diseases in pigs, and the development of new and innovative vaccines.

2. What are some of the challenges facing the porcine vaccine market?
The porcine vaccine market faces challenges such as the high cost of vaccine development and production, regulatory hurdles, and the need to balance vaccine effectiveness with animal welfare concerns.

3. How are porcine vaccines administered?
Porcine vaccines can be administered through injection or through oral or nasal sprays, depending on the specific vaccine and the needs of the pig.

4. Which regions are expected to experience the fastest growth in the porcine vaccine market?
The Asia Pacific region is expected to be the fastest-growing market for porcine vaccines, due to factors such as the growing demand for pork products in countries such as China and India, and the increasing incidence of infectious diseases in pigs in the region.

Browse Other Related Research Reports from Prophecy Market Insights:
Mono Vaccines: (Epstein-Barr virus) Market, By Age group (Adult, and Pediatrics), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Trends, Analysis and Forecast till 2029

Vaccine Adjuvant Market: By Product Type (Particulate Adjuvants, Emulsion Adjuvants, Pathogen Adjuvants, Combination Adjuvants, and Other Adjuvants), By Route of Administration (Oral, Intranasal, Intramuscular, Subcutaneous, Intradermal, and Others), By Disease Type (Cancer, Infectious Disease, and Others), By Application (Research, Commercial, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Trends, Analysis and Forecast till 2029

Shweta Raskar
Prophecy Market Insights
+ +1 860 531 2574
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.